Future gazing with Hannah Kuchler
Three hot IP issues for the pharmaceutical industry
von Dr Paul England
Sale of Theramex by CVC to Carlyle and PAI Partners completes
von Emma Danks und Suzy Davis
Orphan drug protection: clarification needed
von Dr Paul England
UK medicines – Is the Northern Ireland Protocol now unsustainable?
von Dr Paul England
The UK and the Trans-Pacific Partnership – Could patent conflicts ruin the deal?
Available in English and Japanese
von Dr Paul England
English patent torpedoes and the UPC
von Dr Paul England
Advising Apollo Therapeutics on $145 million financing
von Andrew Edge und Chris Cowley
Compulsory licensing in Germany – the coronavirus crisis and beyond